Aptabio is Drug Discovery in South Korea that focus on Aptabio Therapeutics Inc business. Founded in 2009. They cover business area such as Aptabio Therapeutics Inc, discovery, development, selective inhibitor, enzyme, aptamer-base anti-cancer drug, Lipofector-Q, Plusfector, Lipofector-EXT, Lipofector-EZ, Lipofector-pMAX.
2009
( 15 years old in 2024 )
Aptabio Therapeutics Inc
-
Number 504, Heungdeok IT Valley, 13, Heungdeok 1 ro
Giheunggu
Yongin-si, Gyeonggi-do
South Korea
Private
Aptabio Therapeutics Incdiscoverydevelopmentselective inhibitorenzymeaptamer-base anti-cancer drugLipofector-QPlusfectorLipofector-EXTLipofector-EZLipofector-pMAX
* We use standard office opening hours in near Aptabio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Aptabio is Drug Discovery business from South Korea that founded in 2009 (15 years old in 2024), Aptabio business is focusing on Aptabio Therapeutics Inc.
Aptabio headquarter office and corporate office address is located in Number 504, Heungdeok IT Valley, 13, Heungdeok 1 ro Giheunggu Yongin-si, Gyeonggi-do South Korea.
Aptabio was founded in South Korea.
In 2024, Aptabio is currently focus on Aptabio Therapeutics Inc sector.
Above is snippet of Google Trends for "Aptabio Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Aptabio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
